IBM has recently announced that it plans to incorporate the new RAPIDS open source software into its enterprise-grade data science platform for on-premises, hybrid, and multicloud environments
The International Biomedical Research Alliance, a non-profit organisation which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Dr Ralph Korpman, is joining the Alliance’s board of directors
The Pistoia Alliance, has announced the results of a survey on the adoption of blockchain in the pharmaceutical and life science industries
After three years of working on key algorithmic challenges in CFD (Computational Fluid Dynamics), the ExaFLOW project recaps what has been achieved during the project
Altair has announced the final agenda, including additional speakers, for its 2018 Global Altair Technology Conference, taking place at the Palais des Congrès d’Issy in Paris, France from October 16 –18.
Suse and the University of Delaware have joined the OpenMP ARB, a group of hardware and software vendors and research organisations creating the standard for the most popular shared-memory parallel programming model in use today
Optibrium, Intellegens and Medicines Discovery Catapult have announced that they have been awarded a £1 million grant from Innovate UK to support the development of artificical Intelligence (AI) in drug discovery
Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling
Taking on the challenge to develop a broader platform for new and existing additive manufacturing (AM) technologies the University of Exeter (UK) and Victrex, have announced a strategic partnership to introduce PAEK polymers and composites while improving the performance of the AM processes.
Optibrium, a developer of software for drug discovery, has announced it has signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software
DataDirect Networks has announced that it has completed the acquisition of Tintri for $60 million after an extensive bidding process
Citoxlab, a CRO for non-clinical research, has announced an investment and partnership deal with Experimental Pharmacology and Oncology Berlin-Buch (EPO), a CRO providing services for preclinical oncology research